BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26817709)

  • 1. Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways.
    Al-Onazi AS; Al-Rasheed NM; Attia HA; Al-Rasheed NM; Ahmed RM; Al-Amin MA; Poizat C
    J Pharm Pharmacol; 2016 Feb; 68(2):219-32. PubMed ID: 26817709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenofibrate attenuates diabetic nephropathy in experimental diabetic rat's model via suppression of augmented TGF-β1/Smad3 signaling pathway.
    Al-Rasheed NM; Al-Rasheed NM; Al-Amin MA; Hasan IH; Al-Ajmi HN; Mohammad RA; Attia HA
    Arch Physiol Biochem; 2016 Oct; 122(4):186-194. PubMed ID: 26959841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of centella asiatica granule on the expression of TGF-β
    Ma JW; Wang HT; Liu HF; Ding Y; Bai JQ; Zhang Z
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jan; 34(1):69-73. PubMed ID: 29926663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astragaloside effect on TGF-β1, SMAD2/3, and α-SMA expression in the kidney tissues of diabetic KKAy mice.
    Wang Y; Lin C; Ren Q; Liu Y; Yang X
    Int J Clin Exp Pathol; 2015; 8(6):6828-34. PubMed ID: 26261569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shensong Yangxin Capsule prevents diabetic myocardial fibrosis by inhibiting TGF-β1/Smad signaling.
    Shen N; Li X; Zhou T; Bilal MU; Du N; Hu Y; Qin W; Xie Y; Wang H; Wu J; Ju J; Fang Z; Wang L; Zhang Y
    J Ethnopharmacol; 2014 Nov; 157():161-70. PubMed ID: 25267579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
    Miao Y; Zhang W; Zhong M; Ma X; Qi TG; Sun H
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):366-70. PubMed ID: 17456374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PKC-beta1 mediates glucose-induced Akt activation and TGF-beta1 upregulation in mesangial cells.
    Wu D; Peng F; Zhang B; Ingram AJ; Kelly DJ; Gilbert RE; Gao B; Krepinsky JC
    J Am Soc Nephrol; 2009 Mar; 20(3):554-66. PubMed ID: 19211711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KGF-1 accelerates wound contraction through the TGF-β1/Smad signaling pathway in a double-paracrine manner.
    Peng Y; Wu S; Tang Q; Li S; Peng C
    J Biol Chem; 2019 May; 294(21):8361-8370. PubMed ID: 30894415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.
    Wang A; Ziyadeh FN; Lee EY; Pyagay PE; Sung SH; Sheardown SA; Laping NJ; Chen S
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1657-65. PubMed ID: 17804483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All-Trans Retinoic Acid Attenuates Fibrotic Processes by Downregulating TGF-β1/Smad3 in Early Diabetic Nephropathy.
    Sierra-Mondragon E; Rodríguez-Muñoz R; Namorado-Tonix C; Molina-Jijon E; Romero-Trejo D; Pedraza-Chaverri J; Reyes JL
    Biomolecules; 2019 Sep; 9(10):. PubMed ID: 31557800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chaihuang-Yishen granule inhibits diabetic kidney disease in rats through blocking TGF-β/Smad3 signaling.
    Zhao TT; Zhang HJ; Lu XG; Huang XR; Zhang WK; Wang H; Lan HY; Li P
    PLoS One; 2014; 9(3):e90807. PubMed ID: 24646636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of increased penile expression of transforming growth factor-beta1 and activation of the Smad signaling pathway in erectile dysfunction in streptozotocin-induced diabetic rats.
    Zhang LW; Piao S; Choi MJ; Shin HY; Jin HR; Kim WJ; Song SU; Han JY; Park SH; Mamura M; Kim SJ; Ryu JK; Suh JK
    J Sex Med; 2008 Oct; 5(10):2318-29. PubMed ID: 18778311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the Smad pathway in glomeruli from a spontaneously diabetic rat model, OLETF rats.
    Furuse Y; Hashimoto N; Maekawa M; Toyama Y; Nakao A; Iwamoto I; Sakurai K; Suzuki Y; Yagui K; Yuasa S; Toshimori K; Saito Y
    Nephron Exp Nephrol; 2004; 98(3):e100-8. PubMed ID: 15528945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase Cbeta inhibition attenuates osteopontin expression, macrophage recruitment, and tubulointerstitial injury in advanced experimental diabetic nephropathy.
    Kelly DJ; Chanty A; Gow RM; Zhang Y; Gilbert RE
    J Am Soc Nephrol; 2005 Jun; 16(6):1654-60. PubMed ID: 15843473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from the root of Averrhoa carambola L., protects against diabetic kidney disease by inhibiting TLR4/TGFβ signaling pathway.
    Zhang H; Lu S; Chen L; Huang X; Jiang L; Li Y; Liao P; Wu X; Zhou X; Qin L; Wei J; Huang R
    Int Immunopharmacol; 2020 Mar; 80():106120. PubMed ID: 31972423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of sericine on TGF-beta1/Smad3 signal pathway of diabetic mephropathy rats kidney].
    Song CJ; Fu XM; Li J; Chen ZH
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2011 Feb; 27(1):102-5. PubMed ID: 21560355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Bone Marrow Mesenchymal Stem Cells on Plasminogen Activator Inhibitor-1 and Renal Fibrosis in Rats with Diabetic Nephropathy.
    Lang H; Dai C
    Arch Med Res; 2016 Feb; 47(2):71-7. PubMed ID: 27018336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-peptide reverses TGF-beta1-induced changes in renal proximal tubular cells: implications for treatment of diabetic nephropathy.
    Hills CE; Al-Rasheed N; Al-Rasheed N; Willars GB; Brunskill NJ
    Am J Physiol Renal Physiol; 2009 Mar; 296(3):F614-21. PubMed ID: 19091788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathy.
    Ding D; Du Y; Qiu Z; Yan S; Chen F; Wang M; Yang S; Zhou Y; Hu X; Deng Y; Wang S; Wang L; Zhang H; Wu H; Yu X; Zhou Z; Liao Y; Chen X
    J Mol Med (Berl); 2016 Feb; 94(2):207-18. PubMed ID: 26407577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of Ginsenoside Rg1 and Astragaloside IV reduces oxidative stress and inhibits TGF-β1/Smads signaling cascade on renal fibrosis in rats with diabetic nephropathy.
    Du N; Xu Z; Gao M; Liu P; Sun B; Cao X
    Drug Des Devel Ther; 2018; 12():3517-3524. PubMed ID: 30425453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.